Acute Porphyria Drug Database

Monograph

M01AC05 - Lornoxicam
Propably not porphyrinogenic
PNP

Rationale
Substrate and inhibitor to CYP 2C9. Compare the other oxicams (probably not porphyrinogenic
Chemical description
Solution for injection; 8-16 mg/d. Analgetic and antipyretic oxicam derivative for short-time use where peroral administration is unsuitable. Totally metabolized by hydroxylation (CYP 2C9). Inhibitor of CYP 2C9.

Similar drugs
Explore alternative drugs in similar therapeutic classes M01A / M01AC or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Lornoxicam · Lornoxicam 8mg tablets · Xefo · Xefo 4mg tablets · Xefo 8mg tablets
Denmark
Lornoxicam · Lornoxicam "Takeda" · Xefo · Xefo Rapid
Poland
Xefo Rapid
Latvia
Xefo · Xefo Rapid
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙